Barber Daniel 4
4 · Aquestive Therapeutics, Inc. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Aquestive CEO Daniel Barber Sells 25,000 Shares
What Happened
- Daniel Barber, President and CEO of Aquestive Therapeutics (AQST), disposed of 25,000 shares on 2026-06-15 in an open-market/private sale. The weighted average sale price was $4.1604, resulting in proceeds of approximately $104,010. This was a sale (not a purchase or option exercise).
Key Details
- Transaction date: 2026-06-15; Form 4 filed 2026-06-16 (appears timely).
- Price range reported: $4.14 to $4.235 per share; weighted average $4.1604.
- Shares disposed: 25,000; proceeds ≈ $104,010.
- Shares owned after the transaction: not provided in the information you supplied.
- Footnote: Reporting person offered to provide, upon request by the SEC staff, the issuer, or a security holder, the number of shares sold at each separate price (i.e., breakdown by individual trade prices).
- Transaction code: S (sale).
Context
- Sales by executives can be routine (diversification, liquidity, tax reasons) and do not alone indicate a change in company fundamentals. No evidence in this filing of a 10b5‑1 plan, gift, or option exercise — the filing reports a straightforward sale.
Insider Transaction Report
Form 4
Barber Daniel
President and CEO
Transactions
- Sale
Common Stock
[F1]2026-06-15$4.16/sh−25,000$104,010→ 635,574 total
Footnotes (1)
- [F1]The reported transaction involves sale transactions from $4.14 to $4.235 per share. The weighted average price per share was $4.1604. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
Signature
/s/ Thomas Zalewski, as Attorney-In-Fact|2026-06-17